Aperture Health, Inc. Looks to Leverage the Service Offerings of Doctors on Call
FAIRFIELD, N.J., June 28, 2012 /PRNewswire/ — Aperture Health, Inc. (OTC: APRE) announced today that Comprehensive Geriatric Medicine, P.C., which is doing business as Doctors on Call, and was selected by the Centers for Medicare and Medicaid Services (“CMS”) as one of only sixteen (16) private medical practices nationwide to participate in the Independence At Home Demonstration program (“IAHDP”), is likely to become the driving force behind revenue generation for the company post merger. IAHDP was envisioned and deployed as part of the Patient Protection and Affordable Care Act, intended to assign the medical practice greater accountability for all aspects of patient care at home. Private medical practices chosen by CMS to participate in IAHDP will be monitored for maintaining quality care standards and reducing overall healthcare costs associated with the patients enrolled in the program.
Doctors on Call, led by physicians along with nurse practitioners will provide primary care visits at patient homes, particularly those with multiple chronic conditions and functional limitations. With a focus on providing timely and appropriate care in order to improve quality of care and quality of life for patients; while lowering care costs via maintaining the patient at home for as long as possible.
Dr. Paul Rosenstock, MD, Doctors on Call’s CEO, has led the company to become a premier provider of private medical services to patients at home, currently generating $2,000,000.00 in annual revenues with a history of rapid revenue and profit growth year over year. Additionally, the company is near completion of its first Diagnostic Urgent Care Private Practice Site, which the company’s management projects will help the company reach a projected revenue milestone of over $14,000,000.00 in eighteen (18) months from start up. With plans for at least two (2) additional such sites coupled with the services of Triad Therapeutics, Aperture’s wholly owned home infusion subsidiary, Dr. Rosenstock envisions a very strong future for both entities.
James Hennig, R.Ph, Aperture’s CEO and Chairman of the Board of Directors, reiterated and added, “By combining the clinical and business management expertise of Aperture Health and Doctors on Call, we open additional pathways to medical and pharmaceutical service offerings to homecare patients throughout the NY and NJ areas. Joining forces will allow for a more seamless ‘transition of care’ process for patients from comprehensive physician evaluation through the initiation of pharmaceutical care at home. We anticipate greater leveraging of each subsidiaries’ core competency in an effort to accelerate revenue generation and profitability.”
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad Therapeutics operates a fully JCAHO accredited home IV therapy company, achieving this “gold standard” status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the States of New Jersey, New York and Connecticut, providing opportunity for organic growth. Patient referrals are made from physicians, hospitals, insurance companies, veterinarians and hospice care providers that have established a professional rapport with Triad.
Certain statements in this news release are forward-looking, including (without limitation) growing revenues and earnings, expected results from current projects and attracting new business. Undue reliance should not be placed on such forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties and other unpredictable factors, many of which are beyond the Company’s control. The Company’s actual results, performance and trends could differ materially from those indicated or implied by such statements as a result of various factors, including (without limitation) the continued strengthening of Triad’s selling and marketing functions, continued customer satisfaction, contract renewal, new product development, continued availability of capable dedicated personnel, continued cost management, success and availability of acquisitions, availability of financing and other factors, as well as by factors applicable to most companies such as general economic, competitive and other business and civil conditions. Information regarding certain of those and other risk factors and cautionary statements that could affect future results, performance or trends is discussed in the Company’s OTC Disclosure Statement and unaudited management financials posted on www.pinksheets.com . All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
SOURCE Aperture Health, Inc.